Literature DB >> 20739502

Immunogenicity of an autogenous Streptococcus suis bacterin in preparturient sows and their piglets in relation to protection after weaning.

Christoph Georg Baums1, Christian Brüggemann, Christoph Kock, Andreas Beineke, Karl-Heinz Waldmann, Peter Valentin-Weigand.   

Abstract

Streptococcus suis is an important porcine pathogen causing meningitis and other invasive diseases in piglets of different ages. Application of S. suis serotype 2 bacterins to specific-pathogen-free (SPF) weaning piglets has been demonstrated to protect against the homologous serotype. However, autogenous S. suis bacterins are also applied to sows and suckling piglets in the field. Therefore, comparative evaluation of different bacterin immunization regimes, including sow vaccination, was performed in this study. The main objectives were to determine the immunogenicity of an S. suis bacterin in sows prepartum and its influence on active immunization of piglets. Experimental infection of 6- and 8-week-old weaning piglets was performed to elucidate protective efficacies. Humoral immune responses were investigated by an enzyme-linked immunosorbent assay (ELISA) measuring muramidase-released protein (MRP)-specific IgG titers and by opsonophagocytosis assays. Bacterin application elicited high MRP-specific IgG titers in the serum and colostrum of sows, as well as opsonizing antibodies. Piglets from vaccinated sows had significantly higher MRP-specific titers than respective piglets from nonvaccinated sows until 6 weeks postpartum. Vaccination of suckling piglets did not result in high MRP-specific titers nor in induction of opsonizing antibodies. Furthermore, neither vaccination of suckling nor of weaning piglets from immunized sows was associated with a prominent active immune response and protection at 8 weeks postpartum. However, protection was observed in respective 6-week-old weaning piglets, most likely because of protective maternal immunity. In conclusion, this study provides the first results suggesting protective passive maternal immunity for S. suis serotype 2 after bacterin vaccination of sows and a strong inhibitory effect on active immunization of suckling and weaning piglets, leading to highly susceptible growers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739502      PMCID: PMC2953004          DOI: 10.1128/CVI.00159-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  23 in total

1.  Virulence-associated gene profiling of Streptococcus suis isolates by PCR.

Authors:  Luciana M G Silva; Christoph G Baums; Thomas Rehm; Henk J Wisselink; Ralph Goethe; Peter Valentin-Weigand
Journal:  Vet Microbiol       Date:  2006-01-20       Impact factor: 3.293

2.  Porcine IgG: structure, genetics, and evolution.

Authors:  J E Butler; Nancy Wertz; Nicholas Deschacht; Imre Kacskovics
Journal:  Immunogenetics       Date:  2008-12-02       Impact factor: 2.846

Review 3.  Immunoglobulins, antibody repertoire and B cell development.

Authors:  J E Butler; Y Zhao; M Sinkora; N Wertz; I Kacskovics
Journal:  Dev Comp Immunol       Date:  2008-09-18       Impact factor: 3.636

4.  Identification of a novel virulence determinant with serum opacification activity in Streptococcus suis.

Authors:  Christoph G Baums; Ute Kaim; Marcus Fulde; Girish Ramachandran; Ralph Goethe; Peter Valentin-Weigand
Journal:  Infect Immun       Date:  2006-11       Impact factor: 3.441

5.  Comparative evaluation of virulence and pathology of Streptococcus suis serotypes 2 and 9 in experimentally infected growers.

Authors:  Andreas Beineke; Katharina Bennecke; Christina Neis; Charlotte Schröder; Karl-Heinz Waldmann; Wolfgang Baumgärtner; Peter Valentin-Weigand; Christoph Georg Baums
Journal:  Vet Microbiol       Date:  2007-11-04       Impact factor: 3.293

6.  Streptococcus suis bacterin and subunit vaccine immunogenicities and protective efficacies against serotypes 2 and 9.

Authors:  Christoph Georg Baums; Christoph Kock; Andreas Beineke; Katharina Bennecke; Ralph Goethe; Charlotte Schröder; Karl-Heinz Waldmann; Peter Valentin-Weigand
Journal:  Clin Vaccine Immunol       Date:  2008-12-24

7.  Immunization with recombinant Sao protein confers protection against Streptococcus suis infection.

Authors:  Yuanyi Li; Marcelo Gottschalk; Miriam Esgleas; Sonia Lacouture; J Daniel Dubreuil; Philip Willson; Josee Harel
Journal:  Clin Vaccine Immunol       Date:  2007-06-13

8.  Intranasal immunization with a live Streptococcus suis isogenic ofs mutant elicited suilysin-neutralization titers but failed to induce opsonizing antibodies and protection.

Authors:  Christoph Kock; Andreas Beineke; Maren Seitz; Martin Ganter; Karl-Heinz Waldmann; Peter Valentin-Weigand; Christoph Georg Baums
Journal:  Vet Immunol Immunopathol       Date:  2009-05-18       Impact factor: 2.046

Review 9.  Streptococcus suis infections in humans: the Chinese experience and the situation in North America.

Authors:  Marcelo Gottschalk; Mariela Segura; Jiangu Xu
Journal:  Anim Health Res Rev       Date:  2007-06       Impact factor: 2.615

Review 10.  Surface-associated and secreted factors of Streptococcus suis in epidemiology, pathogenesis and vaccine development.

Authors:  Christoph Georg Baums; Peter Valentin-Weigand
Journal:  Anim Health Res Rev       Date:  2009-06       Impact factor: 2.615

View more
  13 in total

1.  Field studies evaluating the direct, indirect, total, and overall efficacy of Streptococcus suis autogenous vaccine in nursery pigs.

Authors:  Danielle Hopkins; Zvonimir Poljak; Abdolvahab Farzan; Robert Friendship
Journal:  Can Vet J       Date:  2019-04       Impact factor: 1.008

2.  Muramidase-released protein of Streptococcus suis: New insight into its impact on virulence.

Authors:  Christian Schwerk
Journal:  Virulence       Date:  2017-05-03       Impact factor: 5.882

3.  Antibody response specific to the capsular polysaccharide is impaired in Streptococcus suis serotype 2-infected animals.

Authors:  Cynthia Calzas; Paul Lemire; Gael Auray; Volker Gerdts; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2014-11-10       Impact factor: 3.441

4.  Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.

Authors:  Guillaume Goyette-Desjardins; Cynthia Calzas; Tze Chieh Shiao; Axel Neubauer; Jennifer Kempker; René Roy; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

5.  Effect of Simultaneous Exposure of Pigs to Streptococcus suis Serotypes 2 and 9 on Their Colonization and Transmission, and on Mortality.

Authors:  Niels Dekker; Annemarie Bouma; Ineke Daemen; Hans Vernooij; Leo van Leengoed; Jaap A Wagenaar; Arjan Stegeman
Journal:  Pathogens       Date:  2017-09-27

6.  Porcine Dendritic Cells as an In Vitro Model to Assess the Immunological Behaviour of Streptococcus suis Subunit Vaccine Formulations and the Polarizing Effect of Adjuvants.

Authors:  Léa Martelet; Sonia Lacouture; Guillaume Goyette-Desjardins; Guy Beauchamp; Charles Surprenant; Marcelo Gottschalk; Mariela Segura
Journal:  Pathogens       Date:  2017-03-22

7.  The inflammatory response and neuronal injury in Streptococcus suis meningitis.

Authors:  Jana Seele; Simone C Tauber; Stephanie Bunkowski; Christoph G Baums; Peter Valentin-Weigand; Nicole de Buhr; Andreas Beineke; Asparouh I Iliev; Wolfgang Brück; Roland Nau
Journal:  BMC Infect Dis       Date:  2018-07-03       Impact factor: 3.090

8.  Immunogenicity study of a Streptococcus suis autogenous vaccine in preparturient sows and evaluation of passive maternal immunity in piglets.

Authors:  Lorelei Corsaut; Léa Martelet; Guillaume Goyette-Desjardins; Guy Beauchamp; Martine Denicourt; Marcelo Gottschalk; Mariela Segura
Journal:  BMC Vet Res       Date:  2021-02-05       Impact factor: 2.741

Review 9.  A critical review speculating on the protective efficacies of autogenous Streptococcus suis bacterins as used in Europe.

Authors:  Karoline Rieckmann; Sophia-Mareike Pendzialek; Thomas Vahlenkamp; Christoph G Baums
Journal:  Porcine Health Manag       Date:  2020-05-06

10.  Comparative Study of Immunogenic Properties of Purified Capsular Polysaccharides from Streptococcus suis Serotypes 3, 7, 8, and 9: the Serotype 3 Polysaccharide Induces an Opsonizing IgG Response.

Authors:  Guillaume Goyette-Desjardins; Jean-Philippe Auger; Dominic Dolbec; Evgeny Vinogradov; Masatoshi Okura; Daisuke Takamatsu; Marie-Rose Van Calsteren; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.